Recipharm, a global Contract Development and Manufacturing Organisation (CDMO), helps bring drugs from concept to market for companies around the world. As its supplier base expanded, Recipharm faced growing pressure to maintain speed and quality across a complex global network. Limited internal audit capacity, suppliers preferring independent auditors, and short-notice qualification needs from acquisitions and new product launches risked creating bottlenecks.
By partnering with Qualifyze, Recipharm introduced an agile model for supplier qualification, expanding the supplier audit capacity by 50% through a three-year, 50-audit-per-year subscription. The subscription established a scalable, cost-efficient foundation. The strategic partnership now is a key part of Recipharm’s ability to maintain compliance, ensure supply continuity, and accelerate innovation across its global operations.
As one of the world’s leading contract development and manufacturing organizations (CDMOs), Recipharm manages a vast and evolving supplier landscape—spanning APIs, excipients, bioprocessing systems, medical devices, and clinical materials….
